BC
Birchview Capital Portfolio holdings
AUM
$171M
1-Year Est. Return
85.36%
This Fund
S&P 500
1 Year Est. Return
+85.36%
AUM
$171M
AUM Growth
+$38.4M
(+29%)
Holding
80
Top Buys
| 1 | +$6.27M | |
| 2 | +$3.52M | |
| 3 | +$3.32M | |
| 4 |
BCYC
Bicycle Therapeutics
BCYC
|
+$2.28M |
| 5 |
Solid Biosciences
SLDB
|
+$2.22M |
Top Sells
| 1 | +$2.12M | |
| 2 | +$1.91M | |
| 3 | +$1.85M | |
| 4 |
Kiniksa Pharmaceuticals
KNSA
|
+$1.16M |
| 5 |
Prothena Corp
PRTA
|
+$1.1M |
Sector Composition
| 1 | Healthcare | 75.96% |
| 2 | Technology | 19.61% |
| 3 | Energy | 3.55% |
| 4 | Materials | 0.54% |
| 5 | Financials | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Avalo Therapeutics
AVTX
$325M
| – | – |
-31,000
|
|
||
77
Axogen
AXGN
$1.51B
| – | – |
-119,078
|
|
||
|
ZBIO
78
Zenas BioPharma
ZBIO
$1.36B
| – | – |
-16,500
|
|
||
79
TELA Bio
TELA
$37.7M
| – | – |
-155,000
|
|
||
80
State Street Health Care Select Sector SPDR ETF
XLV
$41.1B
| – | – |
-1,498
|
|